Companies: 10,795·Total market cap: $144.5T
Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc.

ATOSNASDAQHealthcare● Active
$4.55
+$0.08(+1.79%)
Market Cap$39181997
P/E Ratio
52W High$19.35
52W Low$3.76
Overview

Atossa Therapeutics, Inc. (ATOS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ATOS · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-4.37atos eps ttm · atos earnings per shareEarnings history
PE Ratio (TTM)atos pe ratio ttm · atos price to earningsPE Ratio deep dive
Revenue (TTM)0.00atos revenue ttm · atos annual revenueFull revenue history
Dividend YieldNo Dividenddoes atos pay dividends · atos dividend yieldDividend history
Shares Outstanding8.6Matos shares outstanding · atos floatShares outstanding history
Next EarningsAug 11, 2026Est.atos earnings date · atos next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
atossa therapeutics, inc. revenue · atos revenue 2025
FY 2025Net Income-$34.8M▼ 36.33% YoY
202320242025
atossa therapeutics, inc. net income · atos profit 2025
FY 2025EPS$-4.04▼ 34.67% YoY
202320242025
atos eps · atossa therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$37.6MEPS: $-4.37View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis atos a buy · atos analyst rating
Strong Buy
0
Buy
4
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$10.00Low
$4.55Current
$10.00Avg Target119.78% upside
$10.00High
atos price target · atos 12 month forecast

Total: 5 · Buy rate: 80.0%

The ATOS analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing +119.78% upside from the current price of $4.55.

Stock Performance

Full History
1D+1.79%
1W-5.21%
1M-18.75%
3M+0.44%
YTD-48.59%
1Y-66.81%
5Y-95.00%

About Atossa Therapeutics, Inc.

CEOSteven C. Quay
IPO DateNov 8, 2012
Employees15
CountryUS

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medicines. Their primary focus lies in addressing unmet medical needs in women's oncology, espec…

what is atossa therapeutics, inc. · atos stock overview · atossa therapeutics, inc. company profile · who is atossa therapeutics, inc. ceo · atos NASDAQ · atossa therapeutics, inc. headquarters · atossa therapeutics, inc. business segments

About Stock Overview & Key Data

Atossa Therapeutics, Inc. (ATOS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 8, 2012. As of the latest trading session, ATOS stock price is $4.55, with a market capitalization of $39.2M. The stock has returned -66.81% over the past 12 months and -48.59% year-to-date.

According to 5 Wall Street analysts, the consensus rating for Atossa Therapeutics, Inc. stock is Buy, with an average 12-month price target of $10.00. In fiscal year 2025, Atossa Therapeutics, Inc. reported revenue of — and net income of -$34.8M. For detailed data — including Atossa Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Atossa Therapeutics, Inc. (ATOS) stock price is $4.55. The stock is traded on NASDAQ under the ticker symbol ATOS. The 52-week range is $3.76 – $19.35.

ATOS stock priceATOS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice